Friday, April 09, 2021 6:41:13 PM
The mRNA vaccines are 4- to 7-fold less effective against the P.1 variant, which was first discovered in Brazil,
The B.1.351 variant is more troublesome. Studies have shown that the AstraZeneca vaccine was 86 times less effective against this variant, which was first detected in South Africa.
The mRNA vaccines are 6- to 8-fold less effective against this variant, suggesting a significant waning of protection.
Boosters are coming as there are a couple of billion infections ahead of us, billions of Petri dishes for evolving more variants.
Rite Aid likely to vaccinate 10 million doses by end of year. $40 dose should be high margin as regular vaccinations are considered high margin with a $17 administration fee.
$25 Margin? X 10M = $250 million net for year = $4.50 earnings per share
First we have to get past the earnings call this coming week. Preanounced as bad because California, New York and Pennsylvania were in the harshest lockdowns in the nation. Those states are the heart of Rite Aid. An unmatched historically bad quarter is coming. If RAD sells off on earnings I will be buying as it is a one off quarter never to be matched.
The coming two quarters could be a never matched historically profitable for Rite Aid. Regular business is already springing back on top of the vaccination windfall that is coming.
Recent RADCQ News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 01/12/2024 10:00:11 PM
- Rite Aid Banned From Using AI Facial Recognition in FTC Settlement • Dow Jones News • 12/19/2023 10:57:00 PM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM